Shun-Ichi Kimura

Shun-Ichi Kimura

Auto-generated profile, based on publicly available information

Shun-Ichi Kimura

Division of Hematology Jichi Medical University Saitama Medical Center Saitama Japan

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 October 2022 in Journal of Infection and Chemotherapy
Verified
Journal Article
Open access
SKShigeru Kohno
Shigeru Kohno
KIKoichi Izumikawa
Koichi Izumikawa
TTTakahiro Takazono
Takahiro Takazono
TMTaiga Miyazaki
Taiga Miyazaki
MYMinoru Yoshida
Minoru Yoshida
YNYoshihito Niki
Yoshihito Niki

1 September 1998 in The Japanese Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
PDF file
YOYukihiko Orime
Yukihiko Orime
MSMotomi Shiono
Motomi Shiono
HHHiroaki Hata
Hiroaki Hata
SYShinya Yagi
Shinya Yagi
STSaeki Tsukamoto
Saeki Tsukamoto
YSYukiyasu Sezai
Yukiyasu Sezai

14 September 2023 in Blood
Verified
Journal Article
Closed access
PDF file
KUKento Umino
Kento Umino
KMKaoru Morita
Kaoru Morita
TITakashi Ikeda
Takashi Ikeda
SKShin-Ichiro Kawaguchi
Shin-Ichiro Kawaguchi
TNTakashi Nagayama
Takashi Nagayama
YKYoshinobu Kanda
Yoshinobu Kanda
Chronic graft-versus-host disease (cGVHD) is a multiorgan syndrome with clinical features resembling those of autoimmune diseases. Thus, understanding commonalities in the pathophysiology of cGVHD and autoimmune diseases, such as the presence of disease-risk HLA alleles, is imperative for developing novel therapies against cGVHD. Alloantibodies against H-Y antigens encoded on the Y-chromosome are well-described risk factors for cGVHD in female-to-male transplantation. However, because H-Y antigens generally localize intracellularly in the male reproductive organs, how they emerge at affected organ levels remains elusive. Here, by analyzing nationwide registry data stratified per donor–recipient sex, we identified specific HLA class II alleles that contributed to susceptibility to male cGVHD after transplantation from HLA-identical female siblings (HLA-DRB1∗15:02: hazard ratio, 1.28; 95% confidence interval, 1.03-1.58; P = .025). Coexpression of HLA-DRB1∗15:02 efficiently transported full-length H-Y antigens, especially DBY, to the surface. The presence of alloantibodies against DBY/HLA class II complexes significantly predicted the occurrence of cGVHD (68.8% vs 31.7% at 1 year; P = .002). Notably, the ability of HLA class II molecules to transport and present DBY to alloantibodies was closely associated with the susceptibility of HLA class II alleles to cGVHD. DBY specifically colocalized with HLA class II molecules on the dermal vascular endothelium in cGVHD and provoked complement-dependent cytotoxicity. Moreover, these complexes were observed in some male leukemic cells. Altogether, these findings suggest that vascular endothelial cells facilitate alloantibody-mediated cGVHD and highlight that alloantibodies against DBY/HLA class II complexes could be common targets for cGVHD and a graft-versus-leukemia effect.

5 January 2022 in Transplantation and Cellular Therapy
Verified
Journal Article
Open access
SKShun-Ichi Kimura
Shun-Ichi Kimura
KKKazuaki Kameda
Kazuaki Kameda
KHKaito Harada
Kaito Harada
MSMasuho Saburi
Masuho Saburi
KOKeiji Okinaka
Keiji Okinaka
HNHideki Nakasone
Hideki Nakasone

7 September 2021 in Annals of Hematology
Verified
Journal Article
Closed access
PDF file
SKShun-Ichi Kimura
Shun-Ichi Kimura
MTMasaharu Tamaki
Masaharu Tamaki
KOKeiji Okinaka
Keiji Okinaka
SSSachiko Seo
Sachiko Seo
NUNaoyuki Uchida
Naoyuki Uchida
HNHideki Nakasone
Hideki Nakasone

18 January 2023 in Journal of Infection and Chemotherapy
Verified
Journal Article
Closed access
NYNozomu Yoshino
Nozomu Yoshino
SKShun-Ichi Kimura
Shun-Ichi Kimura
AMAkari Matsuoka
Akari Matsuoka
TMTomohiro Meno
Tomohiro Meno
TITakuto Ishikawa
Takuto Ishikawa
YKYoshinobu Kanda
Yoshinobu Kanda